Simo R, Guerci B, Schernthaner G, Gallwitz B, Rosas-Guzman J, Dotta F, Festa A, Zhou M, Kiljanski J
It is possible that weight monitoring was a lower priority for individuals with normal weight, as suggested by the fact that nearly 80% of the population was overweight or obese at the time of switch to DOR and that a large proportion of DOR users were excluded due to the absence of weight measurement
When you make the levels high , it turns into a fat storage hormone
Multiple studies show that people with genetic variants that decrease HMGCR have higher rates of insulin resistance, higher BMI, and decreased pancreatic insulin release
Ozempics manufacturer also produces a semaglutide drug specifically approved for weight management